Dihydrocodeine hydrogen tartrate,Interaction,Medication Side Effects, Information,Medication adverse effects,Exporting,Diagnosis, Medicine Suppliers,Distributors,Information on diseases,Worldwide,Raw Material Suppliers,Exporters,Importers,Prevention,Causes,Injection exporters,Sellers, Buyers,Taj Pharmaceuticals LTd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Dihydrocodeine hydrogen tartrate Taj API

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Dihydrocodeine hydrogentartrate Manufacturers in India Suppliers Dihydrocodeine hydrogentartrate Exporters Distributors Dihydrocodeine hydrogentartrate api active pharmaceuticals ingredients Dihydrocodeine hydrogentartrate manufacturers Side Effects bulk drugs raw material Dihydrocodeine hydrogentartrate companies Side Effects Importers Dihydrocodeine hydrogentartrate Dihydrocodeine hydrogentartrate Exporters Dihydrocodeine hydrogentartrate exporters FDA Dihydrocodeine hydrogentartrate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Dihydrocodeine hydrogentartrate manufacturing pharmaceutical drugs pharmaceutical intermediates Dihydrocodeine hydrogentartrate pharmaceutical chemicals pharmaceutical raw materials Dihydrocodeine hydrogentartrate active pharmaceutical ingredients Dihydrocodeine hydrogentartrate committee active pharmaceutical ingredients manufacturer Dihydrocodeine hydrogentartrate Active Pharmaceutical Ingredients manufacturer Dihydrocodeine hydrogentartrate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Dihydrocodeine hydrogentartrate, Dihydrocodeine hydrogentartrate manufacturer India, Dihydrocodeine hydrogentartrate product, Dihydrocodeine hydrogentartrate products, Api preparation, Certificate of Analysis API manufacturer product, Dihydrocodeine hydrogentartrate anti ulcer product, Certificate of Origin COA Dihydrocodeine hydrogentartrate COS Dihydrocodeine hydrogentartrate, pharmaceutical generic, pharmaceutical drug, medical, Dihydrocodeine hydrogentartrate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Dihydrocodeine hydrogentartrate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Dihydrocodeine hydrogentartrate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Dihydrocodeine hydrogentartrate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Dihydrocodeine hydrogentartrate ingredients, api, HIV Dihydrocodeine hydrogentartrate, tablets, capsules, syrup & protein Dihydrocodeine hydrogentartrate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Dihydrocodeine hydrogentartrate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Dihydrocodeine hydrogentartrate WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

medicine

HOME >> API >> API List 4 >> Dihydrocodeine Hydrogen Tartrate >> Interaction

INTERACTION
Dihydrocodeine hydrogen tartrate CAS Number:5965-13-9

This drug should not be used with the following medications because very serious, possibly fatal interactions may occur: MAO inhibitors (e.g., furazolidone, isocarboxazid, linezolid, moclobemide, phenelzine, procarbazine, rasagiline, selegiline, tranylcypromine).

If you are currently using any of these medications listed above, tell your doctor or pharmacist before starting this medication. Avoid taking MAO inhibitors within 2 weeks before, during, and after treatment with this medication.

Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: drugs for high blood pressure (e.g., methyldopa, reserpine, beta blockers such as metoprolol and atenolol), cimetidine, narcotic antagonists (e.g., naltrexone, naloxone).

Tell your doctor or pharmacist if you also take drugs that cause drowsiness such as: certain antihistamines (e.g., diphenhydramine), anti-seizure drugs (e.g., carbamazepine), medicine for sleep or anxiety (e.g., alprazolam, diazepam, zolpidem), muscle relaxants, narcotic pain relievers (e.g., codeine), psychiatric medicines (e.g., chlorpromazine, risperidone, amitriptyline, trazodone).

Check the labels on all your medicines (e.g., cough-and-cold products, diet aids) because they may contain the same or similar ingredients that could increase your heart rate or blood pressure or cause drowsiness. Ask your pharmacist about using those products safely.

This document does not contain all possible interactions. Therefore, before using this product, tell your doctor or pharmacist of all the products you use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION >>

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturer,Export,Supplies,Manufacturing in India

Acenocoumarol	Aluminium-magnesium	Buprenorphine HCl	Dihydrocodeine hydrogentartrate	Ethylmorphine HCl	Glibornuride	Hydroxychloroquine sulphate	Noroxymorphone	Noscapine base
Oxycodone	Oxymorphone	Phenobarbital acid	Phenobarbital sodium	Thebaine

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.